RASSF2 promoter hypermethylation determines malignant and microenvironmental features in lung cancer

Genes and Immunity · Published 2026-04-22 · DOI 10.1038/s41435-026-00398-y

Authors being retrieved — see the publisher record. https://doi.org/10.1038/s41435-026-00398-y

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Secreted SULF1 protein modulates CD8 + T cell exhaustion by promoting TAM polarization in gastric cancer · Genes and Immunity · 2026 · Same journal
• Immunoglobulin gene polymorphisms shape the naïve B-cell receptor repertoire; relevance to celiac disease · Genes and Immunity · 2026 · Same journal
• Structural and functional consequences of IL33 and IL1RL1 coding variants on IL-33/ST2 signaling · Genes and Immunity · 2026 · Same journal
• Inhibition of cGAS in dendritic cells suppresses maturation and prolongs allograft survival in mice · Genes and Immunity · 2026 · Same journal
• Radiotherapy combined with anti-PD-1 immunotherapy promotes ferroptosis-driven control of hepatocellular carcinoma · Genes and Immunity · 2025 · Same journal
• The tumoural landscape of lymphocytes and immune pathways in immunotherapy-treated melanoma patients · Genes and Immunity · 2026 · Same journal
• A transcriptional signature of resting mast cells is associated with improved disease outcome in HR+HER2- breast cancer · Genes and Immunity · 2026 · Same journal
• IRF3 in viral infections: more than just triggering the interferon response · Genes and Immunity · 2025 · Same journal
• Regulatory mechanisms of ALKBH5/CIITA axis in the synergistic modulation of hepatocellular carcinoma radiotherapy and immunotherapy · Genes and Immunity · 2026 · Same journal
• Decoding miRNA-Mediated Immunoregulation in SARS-CoV-2, HBV, HIV, and HSV Infections · Genes and Immunity · 2026 · Same journal